BB&T Securities’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-12,456
| Closed | -$188K | – | 1613 |
|
|
2018
Q4 | $188K | Sell |
12,456
-300
| -2% | -$4.53K | ﹤0.01% | 1364 |
|
|
2018
Q3 | $260K | Buy |
12,756
+61
| +0.5% | +$1.24K | ﹤0.01% | 1372 |
|
|
2018
Q2 | $238K | Buy |
12,695
+2,000
| +19% | +$37.5K | ﹤0.01% | 1373 |
|
|
2018
Q1 | $205K | Sell |
10,695
-1,000
| -9% | -$19.2K | ﹤0.01% | 1384 |
|
|
2017
Q4 | $229K | Sell |
11,695
-516
| -4% | -$10.1K | ﹤0.01% | 1285 |
|
|
2017
Q3 | $262K | Sell |
12,211
-1,750
| -13% | -$37.5K | ﹤0.01% | 1189 |
|
|
2017
Q2 | $291K | Buy |
13,961
+161
| +1% | +$3.36K | ﹤0.01% | 1151 |
|
|
2017
Q1 | $267K | Sell |
13,800
-11,850
| -46% | -$229K | ﹤0.01% | 1079 |
|
|
2016
Q4 | $480K | Hold |
25,650
| – | – | 0.01% | 842 |
|
|
2016
Q3 | $480K | Buy |
25,650
+4,000
| +18% | +$74.9K | 0.01% | 843 |
|
|
2016
Q2 | $372K | Buy |
+21,650
| New | +$372K | 0.01% | 893 |
|